de
en

Company
Services
Sectors
Transactions
Team
Insights
News
Career
Contact

Cowen advises Gilead Sciences, Inc. on the sale of Spleen Tyrosine Kinase (SYK) Inhibitor Portfolio to Kronos Bio

July 2020

Similar Transactions

Recent Transactions

13. March 2023
TD COWEN ADVISES SILICON RADAR ON THE SALE TO INDIE SEMICONDUCTOR
21. December 2022
Cowen advises AUCTUS on the sale of Werksarztzentrum
5. December 2022
Cowen Acted As the Exclusive Financial Advisor to SEMSYSCO

Recent News

13. March 2023
TD COWEN ADVISES SILICON RADAR ON THE SALE TO INDIE SEMICONDUCTOR
1. March 2023
TD completes acquisition of Cowen Inc.
26. January 2023
How BYD and NIO are shaking up the German auto industry. An assessment by partner Tobias Seige, Mobility sector expert.

Subscribe to Newsletter

To subscribe to our Newsletter, please use the following link.

© 2023 TD Cowen Continental Europe

Imprint
Privacy
Contact